venBio

San Francisco, California

Firm Location:San Francisco, California • Burlingame, California • San Francisco Bay Area

Investor Firms That Co-Invest with venBio

Polaris Partners Foresite Capital Versant Ventures Lilly Asia Ventures Venrock RA Capital Management Third Rock Ventures OrbiMed Westlake Village BioPartners 5am Ventures Novo Ventures Vivo Capital Perceptive Advisors Samsara BioCapital Sofinnova Investments Foresite Capital Management Xelas Consulting LLC Beta Bridge Capital venBio Partners

venBio Team

Photo of Jaume Pons, Venture Partner at venBio

venBio·Venture Partner

Sweet spot: $25.0M

Range: $20.0M - $30.0M

Investors in California

Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Jaume

Photo of Aaron Royston, Managing Partner at venBio

venBio·Managing Partner

Sweet spot: $25.0M

Range: $20.0M - $30.0M

Investors in SF Bay Area (CA)

Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Aaron

Photo of Yvonne Yamanaka, Principal at venBio

Yvonne Yamanaka

venBio·Principal

Sweet spot: $25.0M

Range: $20.0M - $30.0M

Investors in SF Bay Area (CA)

Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A)

to see your intro paths to Yvonne